Episode 80: Listener comments and questions with an attempt at answers – Part II
In episode 80, Mike and James continue getting back to listener questions. We discuss such topics as glucose monitoring, ezetimibe, niacin, nebulised salbutamol and niacin with uncanny intuitive insight coupled with a degree of emotional sensitivity rarely encountered in podcasts. We then wake up and get Peter Loewen to help answer a difficult question on oral anticoagulants. Show notes 1) Self-monitoring of blood glucose ESMON BMJ 2008;336:1174-7 DiGEM BMJ 2008;336:1177-80 CADTH – thorough review of the issue of glucose monitoring 2) Ezetimibe ENHANCE N Engl J Med 2008;358:1431-43 SEAS N Engl J Med 2008;359:1343-56 Cancer data N Engl J Med 2008;359:1357-66 3) Ezetimibe vs niacin – niacin better? ARBITER 6–HALTS N Engl J Med 2009;361:2113-22 4) Torcetrapib – worsens outcomes N Engl J Med 2007;357:2109-22 5) Niacin Coronary drug project Eur J Clin Pharmacol 1991;40 [Suppl 1]: S49-S51 6) Anticoagulation issues SARS (ASA, ASA+warf, ASA+ticlopidine) post ACS+stent NEJM 1998;339:1665-71 Registry of AF patients on OAC at time of PCI+stent JACC 2008;51:818–25 Registry of OAC patients (various indications) post PCI+DES J Intern Med 2008;264:472-80 Registry of OAC patients (various indications) post PCI+stent J Invasive Cardiol 2006;18:162-4
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!